11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
about
Clozapine: a review of clinical practice guidelines and prescribing trendsThe shock of the new: progress in schizophrenia genomicsSuicide in schizophreniaPharmacological interventions for clozapine-induced sinus tachycardiaHorticultural therapy for schizophreniaTrifluoperazine versus placebo for schizophreniaMaintenance treatment with antipsychotic drugs for schizophreniaFlupenthixol versus placebo for schizophreniaTrifluoperazine versus placebo for schizophreniaQuetiapine versus placebo for schizophreniaFlupenthixol versus placebo for schizophreniaHorticultural therapy for schizophreniaManagement of antipsychotic-related weight gainPharmacological interventions for clozapine-induced sinus tachycardiaEtiology of cardiovascular disease in patients with schizophrenia: current perspectivesCurrent approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatmentsTwo patients walk into a clinic...a genomics perspective on the future of schizophreniaAll-cause and external mortality in released prisoners: systematic review and meta-analysisComorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates TreatmentDo Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating OverviewTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsAssociation between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gainClozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical reviewExploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case studyA semi-supervised method for drug-target interaction prediction with consistency in networksThe antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouseSystematic Review of Clozapine Cardiotoxicity.Psychiatric disease as a risk factor in fast-track hip and knee replacementExcess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.Mortality in schizophrenia and related psychoses: data from two cohorts, 1875-1924 and 1994-2010Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) studyMetabolic syndrome in antipsychotic naïve patients with schizophrenia: pooled analysis of data from three Indian studies.[Comorbid somatic illnesses in psychiatric inpatients - an analysis of administrative data].Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial.Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.Assessing QT interval prolongation and its associated risks with antipsychotics.Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action.All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study.Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based studyMortality in schizophrenia: clinical and serological predictors
P2860
Q21260307-46F0709A-73E1-492A-944B-BB842940C1A4Q22241409-105AEC11-5A81-4942-887B-65FD1F1EE990Q22241477-8D676958-AD5A-444B-8EF9-94B1FA1BA488Q24187704-9009B539-6833-42A1-9113-6FB9663FC465Q24194604-28563C35-6F98-4444-84D5-2009281B250DQ24197679-6EFCB601-A44A-4CF0-B6E1-C5978380E2BAQ24197902-7D088E3F-C484-401D-A2FF-B22CE1D3314BQ24200708-3DD07923-E80F-48A4-AEE2-FBB3E36334ACQ24201149-A5CCE7B5-AD3D-478B-B883-F409A5245772Q24202305-EB679149-D911-48A1-945B-997AD412315FQ24202853-1F3B245F-47D8-43C1-A1EA-9610A39451CDQ24235731-4885C580-555D-45F7-8E3E-6498E4CF1860Q24610124-108ACE5C-3853-463D-93DA-977684ECC00AQ26471506-F64A9256-68E5-4B34-A86E-B3C5DE5EA8E6Q26778485-099D4E7D-7DCF-438A-BDA8-6C782D1E5EA9Q27003099-B361ADEA-6356-402D-ABC0-BBE082D9B0E8Q27004669-3DCAE700-89CE-4FB5-BA92-8829545CA532Q27010286-FE45F95A-32C1-492E-A5E8-731BD67306FFQ27015872-8B8D7FE7-4B30-49DA-9C8E-10BCB29A3DCEQ28077687-1122B064-8606-4630-B557-3C60449A6F70Q28079065-DF488FD3-3693-4CE2-97CE-AA29C2090864Q28266158-2B8F1662-938C-4E30-981C-DC381556F60DQ28274106-6284A155-90E6-4302-B302-8C0743E98AD3Q28477582-3DED1153-CF02-4C9D-98D4-443F93B473ECQ28487735-D4F92887-398D-4970-9B3D-2BADAE67C2B9Q28542712-9C3889E6-8A94-4630-8566-08171844EB3FQ30250192-8121B259-B69B-4677-92C0-B235CDCED62DQ30251885-1E2A1FB0-2C97-4D40-8282-D51DF5158EC0Q30379171-1E14203C-77E0-4ADE-B8A2-9D5316D63B91Q30572656-35DA242C-F58E-4F81-AFBD-980B16C2A850Q30661806-152E9469-EB2F-4F6F-A3E0-4D95EC38059FQ30736365-43D1FFCA-3544-4CC0-BE74-F6B98D97EBEDQ30891577-66CC916A-526B-4A76-9D4E-980AF373D162Q30949176-2F7D8FCD-909D-4A14-8942-9B9C0D9A2547Q31115350-B5AA5B03-A486-4EDC-8BDD-1564B4484B9FQ33160123-AA67E974-26B0-4D65-A970-E31C18DA259FQ33540320-A879D9C2-CA61-4FF8-9C31-D48A916F601CQ33710004-0F319BDC-E7BC-4930-B0B9-47AA55617239Q33718205-C9CDD162-4D16-4D7C-AA44-B804F16A5996Q33762540-38762BDB-B715-4B5D-A914-5EDB6E17C0B5
P2860
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@ast
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@en
11-year follow-up of mortality ...... population-based cohort study
@nl
type
label
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@ast
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@en
11-year follow-up of mortality ...... population-based cohort study
@nl
prefLabel
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@ast
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@en
11-year follow-up of mortality ...... population-based cohort study
@nl
P2093
P50
P1433
P1476
11-year follow-up of mortality ...... ed cohort study (FIN11 study).
@en
P2093
Antti Tanskanen
Leo Niskanen
Timo Klaukka
P304
P356
10.1016/S0140-6736(09)60742-X
P407
P577
2009-08-01T00:00:00Z